Inventor · disambiguated record
Satheesh B. Ravula
Also filed as: RAVULA SATHEESH · RAVULA SATHEESH B · RAVULA SATHEESH BABU
12 granted patents·5 pending applications·9 citations·filing 2011–2023
84Inventor score
Files withEPIGEN BIOSCIENCES INC7CURTANA PHARMACEUTICALS INC5BRUIN BIOSCIENCES INC2CALIFIA BIO INC2GELBARD HARRIS A1
Top patents by PatentIndex Score
17 records- 0183US10570103B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Feb 25, 2020·3 cites·24 claims
- 0282US10227333B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Granted Mar 12, 2019·3 cites·15 claims
- 0375US12234224B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 0475US2023271926A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0572US8846909B2Bicyclic heteroaryl kinase inhibitors and methods of useGELBARD HARRIS A·Filed 2011·Granted Sep 30, 2014·3 cites·19 claims
- 0670US12357570B2Chemoembolization agentsBRUIN BIOSCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·18 claims
- 0768US11691951B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·8 claims
- 0867US11427552B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2020·Granted Aug 30, 2022·0 cites·20 claims
- 0965US2021114991A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1063US11866421B2Pyrimidine and pyridine amine compounds and usage thereof in disease treatmentEPIGEN BIOSCIENCES INC·Filed 2021·Granted Jan 9, 2024·0 cites·21 claims
- 1163US2023286928A1Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1262US10526298B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2018·Granted Jan 7, 2020·0 cites·47 claims
- 1361US10000459B2Heterocyclic compounds useful in the treatment of diseaseEPIGEN BIOSCIENCES INC·Filed 2014·Granted Jun 19, 2018·0 cites·19 claims
- 1458US11712418B2Chemoembolization agentsBRUIN BIOSCIENCES INC·Filed 2018·Granted Aug 1, 2023·0 cites·12 claims
- 1548US2018244631A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1641US9370515B2Mixed lineage kinase inhibitors and method of treatmentsCALIFIA BIO INC·Filed 2014·Granted Jun 21, 2016·0 cites·19 claims
- 1732US2016228437A1Mixed lineage kinase inhibitors and method of treatmentsCALIFIA BIO INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →